"We hope to not only alleviate the increasing burdens on radiologists worldwide but also reduce disparities in healthcare," one Google AI leader said. 

Scientists at Houston Methodist Hospital developed the intelligent-augmented breast cancer risk calculator, testing it across a large dataset to produce promising results. 

A new AI model helped researchers identify a relationship between background parenchyma enhancement on breast MRI exams and breast cancer risk.

Researchers speculated on several reasons why the United States sees more breast imaging-related lawsuits than its neighbor to the north. 

The findings point to a "real need for better tools to identify which women may benefit from screening and which breast cancers are unlikely to be progressive." 

The technology was able to detect about 20% more cancers when compared to standard screening, without impacting false positives.

Paris, France-based Sonio also recently raised $14 million in series A financing led by Cross Border Impact Ventures. 

What’s more, the model proved beneficial in a large, diverse cohort that included women with benign breast disease and BRCA mutations.